Skip to content

Clinical trials

Phase 3 Dyspareunia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyspareunia Phase: Phase 3 Country / region: United States Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20111
20131
20141
20161
20181
20193
20202
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kissei Pharmaceutical Co., Ltd.4
Center for Vulvovaginal Disorders1
Duramed Research1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
Fred Hutchinson Cancer Center1
Myovant Sciences GmbH1
OHSU Knight Cancer Institute1
Teva Pharmaceuticals USA1
TherapeuticsMD1
Warner Chilcott1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyspareunia13
Dysmenorrhea6
Endometriosis6
Constipation4
Pelvic Pain2
Breast Neoplasms1
Pain1
Vulvodynia1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.